药物性肝损伤：病因的演变(3)

[103]Andrade R J,Lucena M I,Fernandez M C,et al.Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period[J].Gastroenterology,2005,129(2):512-521.

[104]Wai C T.Presentation of drug-induced liver injury in Singapore[J].Singapore Med J,2006,47(2):116-120.

[105]Bjornsson E.Review article: drug-induced liver injury in clinical practice [J].Aliment Pharmacol Ther,2010,32(1):3-13.

[106]Wang L,Liu J,Chin D P.Progress in tuberculosis control and the evolving public health system in China[J].Lancet,2007,369(9562):691-696.

[107]陈万青,郑荣寿,曾红梅,等.中国恶性肿瘤发病趋势分析和预测[J].中华预防医学杂志,2012,46(7):581-586.

[108]Cheng T O.The current state of cardiology in China[J].Int J Cardiol,2004,96(3):425-439.

[109]Okrainec K,Banerjee D K,Eisenberg M J.Coronary artery disease in the developing world[J].Am Heart J,2004,148(1):7-15.

[110]Currie J,Lin W,Zhang W.Patient knowledge and antibiotic abuse: evidence from an audit study in China[J].J Health Econ,2011,30(5):933-949.

原文标题：“我国药物性肝损伤病因演变的Meta分析”，发表于《医学与哲学》2013年第34卷第10B期总第487期，第9-13页。